Topics & News
-
Takanori ABE has attended the oral proceedings (video conference) at the EPO for opposition appeal case between Nichia Corporation and Everlight Electronics.
-
open_in_newTakanori ABE gave a speech entitled "SEPs and the automotive industry in Japan" at the session "Global FRAND Licensing in the Digital Era: Negotiation, Disputes, Remedies, and Resolutions across Jurisdictions" at AIPLA.
-
open_in_newTakanori ABE's article titled "Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing" had been published on Life Sciences Intellectual Property Review.
-
Takanori ABE published the article titled "SEPs and the automotive industry in Japan".
-
open_in_newTakanori ABE's article titled "SEPs and the automotive industry in Japan" had been published on WIPR Patents Live.
-
Takanori ABE has been selected as Top 50 IP Experts of Japan 2022 by Asia IP.
-
Takanori ABE gave a speech entitled "SEPs and the automotive industry in Japan" at WIPR Patents Live.
-
open_in_new"Competition Law and Policy in the Japanese Pharmaceutical Sector" incorporating Takanori ABE's article titled "Will Authorised Biologics deter Biosimilars?- Utilising JFTC’s expertise in drug pricing -" had been published. l OA CC BY-NC-ND 4.0 International License
-
Takanori ABE published the article titled "Japan Supreme Court acquits defendant in Coinhive case".
-
Takanori ABE's article titled "Japan Supreme Court acquits defendant in Coinhive case" had been published on Managing Intellectual Property (SPRING 2022).
-
Takanori ABE's comment appeared in an article titled "JPO must stay neutral in its SEP policy review, urge sources" in Managing Intellectual Property magazine.
-
Takanori ABE gave a speech entitled "A closer look at Japan’s desirable patent system in the era of COVID-19" at the Osaka Institute of Invention and Innovation.
-
Takanori ABE was interviewed by ACI regarding patent litigation in Japan.
-
Takanori ABE gave a speech entitled "Why reverse payment is unlikely to arise in Japan?" at KTK.
-
Takanori ABE gave a speech entitled "Do Clinical Trials for Original Drugs Fall Under The Experimental Use Exception?" at LSPN Connect.
-
Takanori ABE gave a speech entitled "How has Japanese patent litigation been reformed?" at WIPR Patents Live.
-
Takanori ABE's comment appeared in an article titled "Asia patent trends in 2022: SEP rates, court changes and more" in Managing Intellectual Property magazine.
-
Takanori ABE was interviewed by Managing Intellectual Property magazine regarding expected patent litigation trends in Asia in 2022.
- 1
- 2
- 1
- 2
2022